Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056171 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Quetiapine for Pediatric Delirium
A Phase 1 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT02056171 is a Phase 1 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 6 participants.
The verdict
NCT02056171, a Phase 1 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study is designed to assess the safety and efficacy of quetiapine as treatment for pediatric delirium.
Interventions
- OTHER Placebo
- DRUG quetiapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02056171
The ClinicalTrials.gov registry entry for NCT02056171 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02056171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02056171 about?
NCT02056171 is a clinical study titled "Efficacy of Quetiapine for Pediatric Delirium". This study is designed to assess the safety and efficacy of quetiapine as treatment for pediatric delirium.
What is the current status of trial NCT02056171?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2015-03. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02056171?
The interventions under investigation include: Placebo (OTHER), quetiapine (DRUG).
Who is sponsoring clinical trial NCT02056171?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.